Back to REGN

Bellevue Group AG → REGN

Bellevue Group AG REGN Position History

Regeneron Pharmaceuticals, Inc. • Healthcare

Quarters held
8
Latest value
$211.9M
Q3 2026
Peak value
$214.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.8M
Q4 2025$8.9M
Q1 2026$1.2M
Q1 2026$214.1M
Q2 2026$181K
Q2 2026$97.9M
Q3 2026$123K
Q3 2026$211.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$211.9M279.4K——
Q3 2026$123K162——
Q2 2026$97.9M157.0K——
Q2 2026$181K291——
Q1 2026$214.1M277.1K——
Q1 2026$1.2M1.5K——
Q4 2025$8.9M11.6K——
Q4 2025$1.8M2.4K——

Other funds holding REGN

Other Bellevue Group AG positions

RVMDW

REVOLUTION MEDICINES INC

$398.3M
ARGX

ARGENX SE

$386M
IONS

IONIS PHARMACEUTICALS INC

$377.7M
AMGN

AMGEN INC

$350.5M
GILD

GILEAD SCIENCES INC

$312M
VRTX

VERTEX PHARMACEUTICALS INC

$302.6M
AMGN

AMGEN INC

$301.1M
VRTX

VERTEX PHARMACEUTICALS INC

$298M